Embecta (EMBC) Cash from Financing Activities (2020 - 2026)

Embecta's (EMBC) quarterly Cash from Financing Activities came in at -$41.5 million in Q1 2026, down 11.26% year-on-year from -$46.8 million in Q1 2025, and up 19.57% quarter-over-quarter from -$51.6 million in Q4 2025.

Embecta (EMBC) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Embecta has disclosed Cash from Financing Activities across 7 years of filings, most recently posting -$41.5 million for Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at -$41.5 million, down 11.26% year-over-year; the trailing twelve-month figure through Mar 2026 was -$237.3 million (down 81.7% YoY), and the FY2025 annual result was -$226.7 million, down 208.86% from the prior year.
  • Cash from Financing Activities came in at -$41.5 million for Q1 2026 at Embecta, up from -$51.6 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $90.3 million in Q1 2022 to a low of -$81.6 million in Q3 2025.
  • The 5-year median for Cash from Financing Activities is -$13.5 million (2023), against an average of -$20.9 million.
  • Across the five-year window, Cash from Financing Activities soared 179.63% in 2022 and plunged 469.7% in 2023, its largest moves.
  • Embecta's Cash from Financing Activities stood at -$6.1 million in 2022, then plunged by 121.31% to -$13.5 million in 2023, then slumped by 234.81% to -$45.2 million in 2024, then dropped by 14.16% to -$51.6 million in 2025, then climbed by 19.57% to -$41.5 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$41.5 million (Q1 2026), -$51.6 million (Q4 2025), and -$81.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -1.35 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -414.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -13.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn -255.24 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn -308.70 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -50.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -75.80 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -48.13 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -11.00 Mn
10 Embecta 183.23 Mn -10.17 Mn 127.80 Mn -41.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -41.50 Mn
Mar 31, 2026 -41.50 Mn
Dec 31, 2025 -51.60 Mn
Dec 31, 2025 -51.60 Mn
Sep 30, 2025 -81.60 Mn
Sep 30, 2025 -81.60 Mn
Jun 30, 2025 -62.60 Mn
Jun 30, 2025 -62.60 Mn
Mar 31, 2025 -37.30 Mn
Mar 31, 2025 -37.30 Mn
Dec 31, 2024 -45.20 Mn
Dec 31, 2024 -45.20 Mn
Sep 30, 2024 -36.60 Mn
Sep 30, 2024 -36.60 Mn
Jun 30, 2024 -11.50 Mn
Jun 30, 2024 -11.50 Mn
Mar 31, 2024 -11.80 Mn
Mar 31, 2024 -11.80 Mn
Dec 31, 2023 -13.50 Mn
Dec 31, 2023 -13.50 Mn